We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
-5.15%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$11.5B
AUM Growth
-$701M
Cap. Flow
+$41.6M
Cap. Flow %
0.36%
Top 10 Hldgs %
19.96%
Holding
1,057
New
67
Increased
411
Reduced
431
Closed
65

Top Sells

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$46.7M
2
NEM icon
Newmont
NEM
+$40.5M
3
MDT icon
Medtronic
MDT
+$39.8M
4
SONY icon
Sony
SONY
+$31.5M
5
ALGN icon
Align Technology
ALGN
+$23.8M

Sector Composition

Rank Sector Weight
1 Financials 16.74%
2 Technology 12.07%
3 Consumer Discretionary 10.51%
4 Healthcare 10.05%
5 Industrials 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSFE icon
976
Paysafe
PSFE
$414M
$47K ﹤0.01%
2,833
DS
977
DELISTED
Drive Shack Inc.
DS
$40K ﹤0.01%
65,000
-100,000
-61% -$119K
MTTR
978
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$39K ﹤0.01%
10,250
-5,000
-33% -$22K
CIK
979
Credit Suisse Asset Management Income Fund
CIK
$134M
$38K ﹤0.01%
14,500
OXSQ icon
980
Oxford Square Capital
OXSQ
$163M
$30K ﹤0.01%
10,000
PLX icon
981
Protalix BioTherapeutics
PLX
$191M
$23K ﹤0.01%
22,000
SMSI icon
982
Smith Micro Software
SMSI
$14.5M
$23K ﹤0.01%
+250
New +$25.4K
OPALW
983
DELISTED
OPAL Fuels Inc. Warrant
OPALW
$22K ﹤0.01%
+15,300
New +$20.8K
MBIO icon
984
Mustang Bio
MBIO
$4.32M
$17K ﹤0.01%
47
RCAT icon
985
Red Cat Holdings
RCAT
$1.15B
$17K ﹤0.01%
10,000
NBSE
986
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$16K ﹤0.01%
2,025
-250
-11% -$4.14K
XXII
987
22nd Century Group
XXII
$1.38M
0
CELG.RT
988
Bristol-Myers Squibb Rights
CELG.RT
$191M
$13K ﹤0.01%
93,770
NRXP icon
989
NRX Pharmaceuticals
NRXP
$135M
$7K ﹤0.01%
1,000
NEXI
990
DELISTED
NexImmune, Inc. Common Stock
NEXI
$6K ﹤0.01%
+420
New +$12.3K
QTNT
991
DELISTED
Quotient Limited Ordinary Shares
QTNT
$2K ﹤0.01%
368
-18
-5% -$162
CONXW
992
DELISTED
CONX Corp. Warrant
CONXW
$1K ﹤0.01%
14,250
AAL icon
993
American Airlines Group
AAL
$10.1B
-10,622
Closed -$135K
ANSS
994
DELISTED
Ansys
ANSS
-852
Closed -$204K
BRX icon
995
Brixmor Property Group
BRX
$9.67B
-16,200
Closed -$327K
BSCP
996
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
-13,165
Closed -$269K
CDW icon
997
CDW
CDW
$18.9B
-5,237
Closed -$825K
CRL icon
998
Charles River Laboratories
CRL
$11.2B
-939
Closed -$201K
CYCN icon
999
Cyclerion Therapeutics
CYCN
$14.9M
-650
Closed -$7K
DBRG icon
1000
DigitalBridge
DBRG
$2.93B
-3,755
Closed -$73K

Similar funds

Davenport & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Davenport & Co held 1,057 positions worth $11.5B, down 5.7% from $12.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Davenport & Co's Q3 2022 filing shows 67 new, 411 increased, 431 reduced and 65 closed positions. Its largest new stake was iShares Russell Top 200 Growth ETF: 51,746 shares worth $6.18M. The largest sale was Caesars Entertainment, an estimated $46.7M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Davenport & Co's largest Q3 2022 buy was iShares Russell Top 200 Growth ETF: 51,746 shares worth $6.18M.
  • Davenport & Co added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $39M increase.
  • Davenport & Co's biggest Q3 2022 reduction was Caesars Entertainment, cutting an estimated $46.7M.
  • Davenport & Co fully exited TransUnion in Q3 2022, selling an estimated $3.4M.
  • Davenport & Co's ten largest holdings make up 20% of its $11.5B portfolio in Q3 2022.
  • Davenport & Co opened 67 new positions and closed 65 in Q3 2022.
  • Davenport & Co's portfolio value fell 5.7% quarter-over-quarter to $11.5B.

Based on Davenport & Co's 13F filing for Q3 2022, filed 11 Oct 2022.